Literature DB >> 24666287

Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography.

Simon Lindner1, Christina Michler, Stephanie Leidner, Christian Rensch, Carmen Wängler, Ralf Schirrmacher, Peter Bartenstein, Björn Wängler.   

Abstract

Gastrin-releasing-peptide (GRP)-receptors and αvβ3-integrins are widely discussed as potential target structures for oncological imaging with positron emission tomography (PET). Favored by the overexpression of receptors on the surface of tumor cells good imaging characteristics can be achieved with highly specific radiolabeled receptor ligands. PEGylated bombesin (PESIN) derivatives as specific GRP receptor ligands and RGD (one-letter codes for arginine-glycine-aspartic acid) peptides as specific αvβ3 binders were synthesized and tagged with a silicon-fluorine-acceptor (SiFA) moiety. The SiFA synthon allows for a fast and highly efficient isotopic exchange reaction at room temperature giving the [(18)F]fluoride labeled peptides in up to 62% radiochemical yields (d.c.) and ≥99% radiochemical purity in a total synthesis time of less than 20 min. Using nanomolar quantities of precursor high specific activities of up to 60 GBq μmol(-1) were obtained. To compensate the high lipophilicity of the SiFA moiety various hydrophilic structure modifications were introduced leading to significantly reduced logD values. Competitive displacement experiments with the PESIN derivatives showed a 32 to 6 nM affinity to the GRP receptor on PC3 cells, and with the RGD peptides a 7 to 3 μM affinity to the αvβ3 integrins on U87MG cells. All derivatives proved to be stable in human plasma over at least 120 min. Small animal PET measurements and biodistribution studies revealed an enhanced and specific accumulation of the RGD peptide (18)F-SiFA-LysMe3-γ-carboxy-d-Glu-RGD (17) in the tumor tissue of U87MG tumor-bearing mice of 5.3% ID/g whereas the PESIN derivatives showed a high liver uptake and only a low accumulation in the tumor tissue of PC3 xenografts. Stability studies with compound 17 provided further information on its metabolism in vivo. These results altogether demonstrate that the reduction of the overall lipophilicity of SiFA tagged RGD peptides is a promising approach for the generation of novel potent (18)F-labeled imaging agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24666287     DOI: 10.1021/bc400588e

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  9 in total

1.  New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase.

Authors:  Erik A Rodriguez; Ye Wang; Jessica L Crisp; David R Vera; Roger Y Tsien; Richard Ting
Journal:  Bioconjug Chem       Date:  2016-04-27       Impact factor: 4.774

2.  18F-Radiolabeled Panobinostat Allows for Positron Emission Tomography Guided Delivery of a Histone Deacetylase Inhibitor.

Authors:  Harikrishna Kommidi; Umberto Tosi; Uday B Maachani; Hua Guo; Christopher S Marnell; Benedict Law; Mark M Souweidane; Richard Ting
Journal:  ACS Med Chem Lett       Date:  2018-01-17       Impact factor: 4.345

3.  Ortho-Stabilized (18) F-Azido Click Agents and their Application in PET Imaging with Single-Stranded DNA Aptamers.

Authors:  Lu Wang; Orit Jacobson; Din Avdic; Benjamin H Rotstein; Ido D Weiss; Lee Collier; Xiaoyuan Chen; Neil Vasdev; Steven H Liang
Journal:  Angew Chem Int Ed Engl       Date:  2015-08-20       Impact factor: 15.336

Review 4.  Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology.

Authors:  Fei-Fei An; Mark Chan; Harikrishna Kommidi; Richard Ting
Journal:  AJR Am J Roentgenol       Date:  2016-05-25       Impact factor: 3.959

Review 5.  ¹⁸F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals.

Authors:  Vadim Bernard-Gauthier; Carmen Wängler; Esther Schirrmacher; Alexey Kostikov; Klaus Jurkschat; Bjoern Wängler; Ralf Schirrmacher
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

6.  First 18F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo.

Authors:  Andreas Poschenrieder; Theresa Osl; Margret Schottelius; Frauke Hoffmann; Martina Wirtz; Markus Schwaiger; Hans-Jürgen Wester
Journal:  Tomography       Date:  2016-06

7.  Metabolism of a Bioorthogonal PET Tracer Candidate [19F/18F]SiFA-Tetrazine in Mouse Liver Microsomes: Biotransformation Pathways and Defluorination Investigated by UHPLC-HRMS.

Authors:  Sofia Otaru; Hanna Niemikoski; Mirkka Sarparanta; Anu J Airaksinen
Journal:  Mol Pharm       Date:  2020-07-01       Impact factor: 4.939

8.  Evaluation of Organo [18F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers.

Authors:  Sofia Otaru; Surachet Imlimthan; Mirkka Sarparanta; Kerttuli Helariutta; Kristiina Wähälä; Anu J Airaksinen
Journal:  Molecules       Date:  2020-03-07       Impact factor: 4.411

9.  Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors.

Authors:  Alexander Wurzer; Daniel Di Carlo; Alexander Schmidt; Roswitha Beck; Matthias Eiber; Markus Schwaiger; Hans-Jürgen Wester
Journal:  J Nucl Med       Date:  2019-12-20       Impact factor: 10.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.